{"title":"Research highlights","authors":"Hajrah Khawaja","doi":"10.1111/febs.17315","DOIUrl":null,"url":null,"abstract":"<p>In this issue of <i>The FEBS Journal</i>, we highlight a study by Madine <i>et al.</i> that explores a potential treatment strategy for light-chain amyloidosis, and a report by Shortt and colleagues investigating how immunomodulatory imide drugs can impact the cereblon interactome. We also feature work by Polikarpov and co-authors exploring how the enzyme <i>Bl</i>Est2 could be the founding member of a previously unrecognised subgroup of carboxylesterases. Image created using Wordclouds.com.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":94226,"journal":{"name":"The FEBS journal","volume":"291 22","pages":"4890-4891"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/febs.17315","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The FEBS journal","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/febs.17315","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In this issue of The FEBS Journal, we highlight a study by Madine et al. that explores a potential treatment strategy for light-chain amyloidosis, and a report by Shortt and colleagues investigating how immunomodulatory imide drugs can impact the cereblon interactome. We also feature work by Polikarpov and co-authors exploring how the enzyme BlEst2 could be the founding member of a previously unrecognised subgroup of carboxylesterases. Image created using Wordclouds.com.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
